Diana Riebold

Dr. Diana Riebold

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Experimental Parasitology
Verified
Journal Article
Closed access
MHM.C. Holtfreter
M.C. Holtfreter
MLMicha Loebermann
Micha Loebermann
SKS. Klammt
S. Klammt
MSM. Sombetzki
M. Sombetzki
PBP. Bodammer
P. Bodammer
ERE.C. Reisinger
E.C. Reisinger

20 March 2013 in Nephrology
Verified
Journal Article
Closed access
PDF file
CFCarlos Fritzsche
Carlos Fritzsche
DRDiana Riebold
Diana Riebold
AFAndreas Fuehrer
Andreas Fuehrer
AMAndrea Mitzner
Andrea Mitzner
SKSebastian Klammt
Sebastian Klammt
EREmil C Reisinger
Emil C Reisinger

10 June 2017 in Journal of Innate Immunity
Verified
Journal Article
Open access
PDF file
ASAnja E. Schauer
Anja E. Schauer
TKTilman E. Klassert
Tilman E. Klassert
CLCarolin von Lachner
Carolin von Lachner
DRDiana Riebold
Diana Riebold
ASAnne Schneeweiß
Anne Schneeweiß
HSHortense Slevogt
Hortense Slevogt
Streptococcus pneumoniae infections can lead to severe complications with excessive immune activation and tissue damage. Interleukin-37 (IL-37) has gained importance as a suppressor of innate and acquired immunity, and its effects have been therapeutic as they prevent tissue damage in autoimmune and inflammatory diseases. By using RAW macrophages, stably transfected with human IL-37, we showed a 70% decrease in the cytokine levels of IL-6, TNF-α, and IL-1β, and a 2.2-fold reduction of the intracellular killing capacity of internalized pneumococci in response to pneumococcal infection. In a murine model of infection with S. pneumoniae, using mice transgenic for human IL-37b (IL-37tg), we observed an initial decrease in cytokine expression of IL-6, TNF-α, and IL-1β in the lungs, followed by a late-phase enhancement of pneumococcal burden and subsequent increase of proinflammatory cytokine levels. Additionally, a marked increase in recruitment of alveolar macrophages and neutrophils was noted, while TRAIL mRNA was reduced 3-fold in lungs of IL-37tg mice, resulting in necrotizing pneumonia with augmented death of infiltrating neutrophils, enhanced bacteremic spread, and increased mortality. In conclusion, we have identified that IL-37 modulates several core components of a successful inflammatory response to pneumococcal pneumonia, which lead to increased inflammation, tissue damage, and mortality.

9 March 2012 in Scandinavian Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
CFC Fritzsche
C Fritzsche
DRDiana Riebold
Diana Riebold
AMAk Munk-Hartig
Ak Munk-Hartig
SKS Klammt
S Klammt
GNG Neeck
G Neeck
EREc Reisinger
Ec Reisinger
Background: Patients with autoimmune inflammatory diseases (AID) account for 13–36% of Pneumocystis pneumonia (PCP) cases in human immunodeficiency virus (HIV)-negative patients. Up to 88% of PCP cases in HIV-negative patients are associated with prior steroid treatment. Pulmonary colonization with Pneumocystis in HIV-negative patients is associated with corticosteroid therapy in up to 75% of cases. The aim of this study was to detect the prevalence and risk factors of pulmonary colonization with Pneumocystis jirovecii in patients with AID receiving corticosteroid therapy in comparison with healthy control persons. Methods: We investigated induced sputa of 102 patients with AID on current corticosteroid treatment and of 117 healthy controls for the presence of P. jirovecii using polymerase chain reaction (PCR). Results: Twenty-nine patients (28.5%) with AID were colonized with P. jirovecii compared to three healthy controls (2.6%) [p < 0.001, odds ratio (OR) 15.10, 95% confidence interval (CI) 4.43–51.38]. In patients with AID, age over 60 years was significantly associated with colonization (p = 0.015, OR 3.19, 95% CI 1.27–7.94). Multivariate analysis showed age to be independently associated with the colonization of P. jirovecii (95% CI 1.002–1.092). Neither duration nor dose of corticosteroid therapy nor immunosuppressive co-medication had a significant influence on P. jirovecii colonization. Conclusion: Patients with AID, especially those over 60 years of age, display a high prevalence of colonization with P. jirovecii. Clinicians should be aware of this and ensure that they consider the possibility of PCP when pulmonary symptoms arise in these patients.

1 May 2002 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
BSBeate Steiner
Beate Steiner
DRDiana Riebold
Diana Riebold
DWDaniel Wolff
Daniel Wolff
MFMathias Freund
Mathias Freund
EREmil C. Reisinger
Emil C. Reisinger
As pointed out in Siddiqui and Berk's review [1], screening for latent S. stercoralis infection might be a valuable option for patients with a relevant geograph

8 January 2013 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
CFC. Fritzsche
C. Fritzsche
FBF. Becker
F. Becker
CHC. J. Hemmer
C. J. Hemmer
DRDiana Riebold
Diana Riebold
SKS. Klammt
S. Klammt
ERE. C. Reisinger
E. C. Reisinger
Background Healthcare workers (HCW) are at risk of acquiring blood-borne viral infections, particularly hepatitis B (HBV), hepatitis C (HCV), and HIV, especially in high endemic regions such as sub-Saharan Africa. Methods Sera from 237 hospital workers in Southwest Cameroon were tested for anti-hepatitis B core antigen (anti-HBc), hepatitis B surface antigen (HBsAg), anti-hepatitis B surface antigen (anti-HBs), anti-HCV and (on a voluntary basis) for anti-HIV. Information on pre-study testing for HBV, HCV and HIV and pre-study HBV vaccination status was collected from these individuals. Results The pre-study testing rate among participating hospital staff for HBV was 23.6% (56/237), for HCV 16% (38/237), and for HIV 91.6% (217/237). The pre-study HBV vaccination rate was 12.3% (29/237). Analysis of anti-HBc revealed that 73.4% (174/237) of the hospital staff had been infected by HBV. Active HBV infection (HBsAg positivity) was detected in 15 participants. Anti-HCV was found in four of 237 participants, HIV antibodies were detected in four of 200 participants tested. Conclusion HBV and HCV are neglected diseases among HCW in sub-Saharan Africa. The vaccination rate against HBV was very low at 12.3%, and therefore anti-HBc testing should be mandatory to identify HCW requiring HBV vaccination. Testing for HBV and routine HBV vaccination for HBV-negative HCW should be strongly enforced in Cameroon.